NCT04928352View on ClinicalTrials.gov

Nebulized Bupivacaine Analgesia for Cleft Palate Repair

PHASE3RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 14, 2021

Primary Completion Date

August 10, 2026

Study Completion Date

September 20, 2026

Conditions
Cleft Palate
Interventions
DRUG

Bupivacaine Hydrochloride

Preoperative Nebulized Bupivacaine 0.50% 0.25 mg.kg-1

DRUG

Bupivacaine Hydrochloride

Preoperative Nebulized Bupivacaine 0.50% 0.50 mg.kg-1

OTHER

0.9% saline

Preoperative nebulized same volume of saline placebo

Trial Locations (1)

Assuit universi

RECRUITING

Assiut university hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER